FORUS Therapeutics Inc. is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Quebec as of November 6th. Further details on the criteria can be found in the links below:
- Liste des médicaments – Établissement – en vigueur le 6 novembre 2025
- Liste des médicaments – en vigueur le 6 novembre 2025
We are excited about this important milestone for patients in Quebec.
Read on LinkedIn.
Read more on newsfile.